Opinion

Video

Dr. O’Shaughnessy Shares Her Management Strategy for Hematologic Toxicities with Ribociclib

Author(s):

Kirollos S. Hanna, PharmD, BCPS, BCOP,Hope Rugo, MD

A medical expert navigates toxicity management in patients being treated with ribociclib.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Video content above is prompted by the following question(s):

      • How do you monitor for and manage hematologic toxicities seen with ribociclib?
      Related Videos
      Building Better Collaboration: Reducing Care Delays in Managing mCRC
      Building Better Collaboration: Reducing Care Delays in Managing mCRC
      Best Practices for Overcoming mCRC Prior Authorization Barriers
      Best Practices for Overcoming mCRC Prior Authorization Barriers
      Lp(a) Levels: A Continuous Relationship With ASCVD Levels and Consistent Throughout a Lifetime
      Lp(a) Levels: A Continuous Relationship With ASCVD Levels and Consistent Throughout a Lifetime
      Studying the Association Between Elevated Lp(a) Levels and Risk of Atherosclerotic Disease
      Studying the Association Between Elevated Lp(a) Levels and Risk of Atherosclerotic Disease
      Navigating Cost Considerations in Treatment Selection of mCRC Agents
      Navigating Cost Considerations in Treatment Selection of mCRC Agents
      Pharmacist-Led Strategies for Adverse Event Management in mCRC
      Pharmacist-Led Strategies for Adverse Event Management in mCRC
      The Role of Prevention in the Management of Atherosclerotic Disease and Aortic Stenosis
      The Role of Prevention in the Management of Atherosclerotic Disease and Aortic Stenosis
      Introduction and Burden of Atherosclerotic Disease and Aortic Stenosis
      Introduction and Burden of Atherosclerotic Disease and Aortic Stenosis
      Evolution of Oncology Pharmacy Practice in mCRC
      Evolution of Oncology Pharmacy Practice in mCRC
      The Patient Journey: Mapping the Pharmacist’s Role in mCRC Management
      The Patient Journey: Mapping the Pharmacist’s Role in mCRC Management
      Related Content
      Screen-detected breast cancer. | Image Credit: keetazalay - stock.adobe.com
      March 27th 2025

      Interval Breast Cancer Risk High Despite Screening, Highlights Need for Risk-Based Approach

      Cameron Santoro
      Interval breast cancer rates have remained consistent over 30 years despite age-based screening, highlighting the need for risk-based screening strategies that account for factors like breast density, hormone replacement therapy, and family cancer history to improve early detection.
      Managed Care Cast
      October 30th 2023

      Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening

      Pearl Steinzor
      On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
      Pink ribbon for breast cancer | Image Credit: Andrey Popov - stock.adobe.com
      February 17th 2025

      Black Patients With Metastatic Triple-Negative Breast Cancer Are Less Likely to Get Immunotherapy, Study Finds

      Pearl Steinzor
      Racial and ethnic disparities were identified in immunotherapy receipt for Black patients with metastatic triple-negative breast cancer.
      Managed Care Cast
      February 22nd 2022

      The Disproportionate Impact of the Pandemic on Health Care Disparities and Cancer

      On this episode of Managed Care Cast, we discuss how already wide health care inequities in cancer are becoming much worse because of the COVID-19 pandemic, with guest Monica Soni, MD, associate chief medical officer at New Century Health.
      Breast cancer - Crystal light - stock.adobe.com
      February 11th 2025

      Rising Breast Cancer Rates Show Disparities Across Racial, Ethnic Groups in the US

      Pearl Steinzor
      Significant increases in breast cancer incidence were found among Hispanic, American Indian or Alaska Native, and Asian or Pacific Islander women.
      Breast cancer research. | Image Credit: Chinnapong - stock.adobe.com
      February 5th 2025

      How Socioeconomic Factors Shaped Responses to USPSTF Mammography Guidelines

      Pearl Steinzor
      Breast cancer screening rates shifted after the 2009 US Preventive Services Task Force (USPSTF) guidelines, with disparities emerging across race, income, and lifestyle factors.

      2 Commerce Drive
      Suite 100
      Cranbury, NJ 08512

      © 2025 MJH Life Sciences® and AJMC®.
      All rights reserved.

      About
      Contact
      Editorial Boards
      Advertise
      Do Not Sell My Information
      Terms & Conditions
      Privacy Policy
      AJMC Managed Markets Network Logo
      CH LogoCenter for Biosimilars Logo